Sentry Investment Management LLC Sells 2,010 Shares of HCA Healthcare Inc (HCA)
Sentry Investment Management LLC lowered its holdings in shares of HCA Healthcare Inc (NYSE:HCA) by 9.6% during the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 18,962 shares of the company’s stock after selling 2,010 shares during the period. Sentry Investment Management LLC’s holdings in HCA Healthcare were worth $1,946,000 as of its most recent SEC filing.
A number of other institutional investors and hedge funds have also bought and sold shares of the business. FMR LLC boosted its stake in shares of HCA Healthcare by 54.9% in the 2nd quarter. FMR LLC now owns 5,488,273 shares of the company’s stock valued at $563,097,000 after purchasing an additional 1,944,961 shares in the last quarter. LSV Asset Management boosted its stake in shares of HCA Healthcare by 9.2% in the 2nd quarter. LSV Asset Management now owns 5,459,388 shares of the company’s stock valued at $560,133,000 after purchasing an additional 457,752 shares in the last quarter. Massachusetts Financial Services Co. MA boosted its stake in shares of HCA Healthcare by 62.6% in the 2nd quarter. Massachusetts Financial Services Co. MA now owns 891,489 shares of the company’s stock valued at $91,466,000 after purchasing an additional 343,121 shares in the last quarter. Canada Pension Plan Investment Board boosted its stake in shares of HCA Healthcare by 65.3% in the 2nd quarter. Canada Pension Plan Investment Board now owns 800,500 shares of the company’s stock valued at $82,131,000 after purchasing an additional 316,250 shares in the last quarter. Finally, Martingale Asset Management L P boosted its stake in shares of HCA Healthcare by 171.0% in the 2nd quarter. Martingale Asset Management L P now owns 468,031 shares of the company’s stock valued at $48,021,000 after purchasing an additional 295,331 shares in the last quarter. Hedge funds and other institutional investors own 70.40% of the company’s stock.
Several brokerages have recently commented on HCA. Mizuho restated a “buy” rating and issued a $145.00 target price on shares of HCA Healthcare in a research note on Thursday, August 2nd. ValuEngine upgraded shares of HCA Healthcare from a “hold” rating to a “buy” rating in a research note on Wednesday, July 18th. Barclays began coverage on shares of HCA Healthcare in a research note on Tuesday, August 14th. They issued an “overweight” rating and a $150.00 target price on the stock. Jefferies Financial Group restated a “buy” rating and issued a $135.00 target price on shares of HCA Healthcare in a research note on Thursday, July 26th. Finally, Credit Suisse Group boosted their target price on shares of HCA Healthcare from $122.00 to $143.00 and gave the company an “outperform” rating in a research note on Friday, July 27th. Two research analysts have rated the stock with a sell rating, six have assigned a hold rating and eighteen have given a buy rating to the stock. The stock presently has a consensus rating of “Buy” and an average price target of $119.76.
HCA Healthcare stock opened at $131.79 on Friday. The company has a debt-to-equity ratio of -7.64, a current ratio of 1.36 and a quick ratio of 1.15. HCA Healthcare Inc has a 12-month low of $71.18 and a 12-month high of $132.57. The stock has a market capitalization of $45.07 billion, a P/E ratio of 20.00, a price-to-earnings-growth ratio of 1.18 and a beta of 0.53.
HCA Healthcare (NYSE:HCA) last released its quarterly earnings results on Wednesday, July 25th. The company reported $2.29 earnings per share (EPS) for the quarter, beating the Zacks’ consensus estimate of $2.16 by $0.13. HCA Healthcare had a negative return on equity of 61.68% and a net margin of 6.21%. The business had revenue of $11.53 billion during the quarter, compared to analysts’ expectations of $11.32 billion. During the same period in the previous year, the business posted $1.73 earnings per share. The firm’s revenue for the quarter was up 7.4% compared to the same quarter last year. sell-side analysts predict that HCA Healthcare Inc will post 9.23 EPS for the current fiscal year.
The firm also recently declared a quarterly dividend, which will be paid on Friday, September 28th. Investors of record on Tuesday, September 4th will be issued a $0.35 dividend. The ex-dividend date of this dividend is Friday, August 31st. This represents a $1.40 dividend on an annualized basis and a dividend yield of 1.06%. HCA Healthcare’s dividend payout ratio is 21.24%.
About HCA Healthcare
HCA Healthcare, Inc, through its subsidiaries, provides health care services. The company operates general, acute care hospitals that offer medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy services.
Recommended Story: Book Value Per Share in Stock Trading
Want to see what other hedge funds are holding HCA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for HCA Healthcare Inc (NYSE:HCA).
Receive News & Ratings for HCA Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HCA Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.